-
Celltrion’s Avtozma receives FDA approval for multiple conditions
03 Feb 2025 15:58 GMT
… idiopathic arthritis, systemic juvenile idiopathic arthritis and rheumatoid arthritis.
The FDA’ … change from baseline in disease activity score utilising … accessible and high-quality treatment options for patients … the Phase III global trial.
In August last …
-
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist
03 Feb 2025 12:30 GMT
… million payment for existing drug supply. Anaptys is also … , chronic, systemic autoinflammatory disease that is potentially life … company focused on the development and commercialization of … Phase 2b trial for the treatment of rheumatoid arthritis and in …
-
Development and Validation of a Cost-Effective Machine Learning Model for Screening Potential Rheumatoid Arthritis in Primary Healthcare Clinics
03 Feb 2025 12:15 GMT
… can effectively impede disease progression, minimize the … spanning diagnosis, identification, drug efficacy evaluation, prognosis, … China (81974253), Treatment and Prevention Integration … predict the development of rheumatoid arthritis. Arthritis Rheum. 2003 …
-
Was a Novel Eye Treatment Approved Too Soon?
03 Feb 2025 10:13 GMT
… an early form of the disease that can lead to geographic … .
In 2023, the FDA approved two drug treatments for geographic atrophy in … has been used for the treatment of arthritis, skin wounds, and … safety,” he added.
The trial reported an average improvement in …
-
'Obesity Not Just Cosmetic': Eli Lilly Ready For Weight-Loss Drug Mounjaro Launch In India | Interview
03 Feb 2025 08:59 GMT
… This once-weekly injectable prescription medication is designed to help manage … get the same sort of treatment as other chronic diseases.… treat obesity.
“When someone develops obesity and starts a diet … your joints and also causes arthritis. Also, it can cause …
-
FDA Approves Third Tocilizumab Biosimilar
03 Feb 2025 07:59 GMT
The US Food and Drug Administration (FDA) has approved Avtozma (tocilizumab- … juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, and coronavirus disease (COVID-19 … interstitial lung disease.
The biologic is the third FDA-approved …
-
Rheumatoid Arthritis Drugs Market: Trends, Opportunities, and Challenges
03 Feb 2025 07:05 GMT
… , various medications are available to manage symptoms and slow disease progression.
Key … in developing regions enhances patient access to treatments.
Market Segmentation
The rheumatoid arthritis drugs …
-
Rheumatoid Arthritis Day 2025: Know Date, Significance & More Of The Chronic Condition
02 Feb 2025 09:08 GMT
… and misconceptions about this chronic disease. This disease can affect all parts … lifestyle habits and medication, we can manage rheumatoid arthritis.
Rheumatoid Arthritis Day 2025 …
-
Five common healthy foods that could interact with prescription medications
02 Feb 2025 05:33 GMT
… particularly if you take prescription medications
Published Date - 2 … manage symptoms of rheumatoid arthritis and skin conditions such … increase the risk of developing a blood clot.
It …
Other drugs affected by dairy include levothyroxine, a drug used for …
-
US drug regulator approves new non-addictive pain pill
31 Jan 2025 11:47 GMT
… .
The Food and Drug Administration (FDA) said it approved … first new pharmaceutical pain treatment in more than 20 … However, the medication’s modest effectiveness, lengthy development process, and … for common ailments like arthritis and back pain.
…